全文获取类型
收费全文 | 3294篇 |
免费 | 236篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 195篇 |
妇产科学 | 75篇 |
基础医学 | 382篇 |
口腔科学 | 64篇 |
临床医学 | 307篇 |
内科学 | 727篇 |
皮肤病学 | 89篇 |
神经病学 | 177篇 |
特种医学 | 443篇 |
外国民族医学 | 1篇 |
外科学 | 482篇 |
综合类 | 72篇 |
预防医学 | 260篇 |
眼科学 | 22篇 |
药学 | 114篇 |
中国医学 | 2篇 |
肿瘤学 | 180篇 |
出版年
2023年 | 17篇 |
2022年 | 25篇 |
2021年 | 57篇 |
2020年 | 46篇 |
2019年 | 60篇 |
2018年 | 82篇 |
2017年 | 56篇 |
2016年 | 55篇 |
2015年 | 47篇 |
2014年 | 65篇 |
2013年 | 108篇 |
2012年 | 135篇 |
2011年 | 150篇 |
2010年 | 111篇 |
2009年 | 134篇 |
2008年 | 146篇 |
2007年 | 161篇 |
2006年 | 125篇 |
2005年 | 115篇 |
2004年 | 94篇 |
2003年 | 116篇 |
2002年 | 90篇 |
2001年 | 91篇 |
2000年 | 85篇 |
1999年 | 79篇 |
1998年 | 95篇 |
1997年 | 102篇 |
1996年 | 125篇 |
1995年 | 77篇 |
1994年 | 76篇 |
1993年 | 64篇 |
1992年 | 62篇 |
1991年 | 69篇 |
1990年 | 51篇 |
1989年 | 70篇 |
1988年 | 73篇 |
1987年 | 65篇 |
1986年 | 73篇 |
1985年 | 56篇 |
1984年 | 21篇 |
1983年 | 29篇 |
1982年 | 29篇 |
1981年 | 21篇 |
1980年 | 26篇 |
1979年 | 29篇 |
1978年 | 18篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 17篇 |
1967年 | 10篇 |
排序方式: 共有3597条查询结果,搜索用时 703 毫秒
1.
Maren T Scheuner William C Whitworth Henraya McGruder Paula W Yoon Muin J Khoury 《Genetics in medicine》2006,8(8):525-531
PURPOSE: We examined the performance of a familial risk assessment method that stratifies risk for early-onset coronary heart disease by considering the number of relatives with coronary disease, degree of relationship, lineage, and age at diagnosis. METHODS: By using data from the HealthStyles 2003 survey, we assessed the associations between familial risk and early-onset coronary heart disease, diabetes, hypercholesterolemia, hypertension, and obesity. By using area under the curve statistics, we evaluated the discriminatory ability of various risk assessment models. RESULTS: Of 4,035 respondents, 60% were female and 72% were white, with a mean age of 48.8 years. After adjustment for demographics, strong and moderate risk were significantly associated with approximately a five- and twofold risk of early-onset coronary disease, respectively. After adjustment for demographics and personal history of cardiovascular disease, strong familial risk was also significantly associated with diabetes, hypercholesterolemia, hypertension, and obesity. A risk assessment model that included familial risk, demographics, and personal history of diabetes, hypercholesterolemia, hypertension, and obesity was most optimal with an area under the curve statistic of 87.2% CONCLUSIONS: Familial risk assessment can stratify risk for early-onset coronary heart disease. Several conditions associated with increased familial risk can be prevented. These results have important implications for risk assessment and risk-reducing interventions. 相似文献
2.
3.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
4.
5.
The modulation of co-stimulatory pathways represents a novel therapeutic strategy to regulate autoimmune diseases. Auto-reactive
CD4+ T cells play a critical role in initiating the immune response leading to inflammation and autoimmune diseases. Blocking
co-stimulatory signals prevents T-cell activation, thus diminishing autoimmune responses and possibly preventing the progression
of autoimmune disease. Blockade of several co-stimulatory pathways has been investigated in animal models and has led to clinical
trials testing specific blocking agents in humans. In this review we will describe the role of co-stimulatory pathways, primarily
the CD28-B7 pathway, in autoimmune diseases, and we will present in vivo and in vitro studies supporting the efficacy of co-stimulation blockade in animal models of autoimmune disease. Finally, we will discuss
the clinical therapeutic efficacy of blocking monoclonal antibodies in preventing or reducing auto-antigen driven T-cell activation
in humans with particular attention to the CD28/B7 pathway. Inhibiting co-stimulatory molecule interactions by using monoclonal
antibodies seems to be an original approach to regulate autoimmune diseases in humans. 相似文献
6.
7.
8.
M J Khoury W Stewart A Weinstein S Panny P Lindsay M Eisenberg 《Journal of clinical epidemiology》1988,41(1):15-20
Although most teratogens are suspected to act early in the first trimester of pregnancy, birth defects monitoring programs and etiologic studies usually use residence at birth as a proxy measure for residence in the first trimester in searching for environmental teratogens. Because of the high mobility of the U.S. population, residence misclassification can potentially alter inferences concerning environmental teratogens. To evaluate this potential bias, data from the population-based Maryland Birth Defects Reporting and Information System were analyzed. In 1984, the system ascertained 295 infants with one or more of 12 sentinel defects. Of these cases, 59 (20%) mothers reported they have changed address between the time of conception and the time of birth, and 22 have moved to a different county. The residential mobility rate varied by demographic variables and was highest among white women, in the age group 20-24 years. If residence at birth is used as a screening test for residence at conception, it can be shown that in the presence of an environmental teratogenic exposure, misclassification of exposure increases with increasing mobility rate, and population exposure frequency. Such misclassification tends to weaken associations between residence and birth defects and may lead to missing environmental teratogens. This analysis emphasizes the need to use residence information early in pregnancy rather than exclusively at birth. 相似文献
9.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
10.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献